STING1 and neoplasm: In murine models of solid tumors, such as melanoma and lung carcinoma, while defective LAP impairs the degradation of engulfed tumor cells, it stimulates antitumor immunity through the activation of tumor-infiltrating lymphocytes and the secretion of inflammatory mediators downstream of the stimulator of IFN genes (STING) pathway (11).